光學同調斷層掃瞄(OCT)的開發平台(管線) - 開發階段，市場區隔，地區和國家，法規途徑，主要企業(2024年版)

光學相干斷層掃描 (OCT) 設備可以對視網膜進行成像和測量厚度。

本報告提供光學同調斷層掃瞄(OCT)市場相關調查，提供產品概要與正在開發的開發中產品趨勢，各種處於開發階段的產品的比較分析和進行中的臨床試驗相關資訊，參與企業的最近趨勢等資訊。

目錄

第1章 目錄

第2章 簡介

• 光學同調斷層掃瞄(OCT)概要

第3章 開發中的產品

• 光學同調斷層掃瞄(OCT) - 各開發階段平台產品
• 光學同調斷層掃瞄(OCT) - 各地區開發中產品
• 光學同調斷層掃瞄(OCT) - 各法規途徑開發中產品
• 光學同調斷層掃瞄(OCT) - 估計核准日開發中產品
• 光學同調斷層掃瞄(OCT) - 進行中的臨床試驗

第4章 光學同調斷層掃瞄(OCT)- 各公司正在開發的開發中產品

• 光學同調斷層掃瞄(OCT)企業- 各開發階段平台產品
• 光學同調斷層掃瞄(OCT)- 各開發階段的開發中產品

第5章 光學同調斷層掃瞄(OCT)企業和產品概要

• Brown University
• Canon USA Inc
• Columbia University
• Compact Imaging Inc.
• Costruzioni Strumenti Oftalmici Cso Srl
• Digital Diagnostics Inc
• Duke University
• George Washington University
• Heidelberg Engineering GmbH
• Kubota Vision Inc
• Leica Microsystems GmbH
• LighTopTech Corp
• Lumedica Inc
• Massachusetts General Hospital
• MicroPort Scientific Corp
• Moorfields Eye Hospital NHS Foundation Trust
• Myriad Advanced Technologies LLC
• Nippon Telegraph and Telephone Corp
• Notal Vision Inc
• Opticent Inc
• OptoQuest Inc
• Optos Plc
• OptoVibronex LLC
• Optovue Inc
• Oregon Health & Science University
• Physical Sciences Inc
• Rowiak GmbH
• Singapore Eye Research Institute
• Sinoora Inc.
• The University of Texas at Austin Division of Housing and Food Service
• Theia Imaging LLC
• TowardPi Medical Technology Ltd
• Tupai (Beijing) Medical Technology Co Ltd
• University of California Berkeley
• University of Illinois at Chicago
• University of Liverpool
• University of Louisville
• University of Pittsburgh
• University of Rochester
• Vanderbilt University

第6章 光學同調斷層掃瞄(OCT)-最近的趨勢

第7章 附錄

GlobalData's Medical Devices sector report, "Optical Coherence Tomography (OCT) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Optical Coherence Tomography (OCT) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Optical Coherence Tomography (OCT) equipment allows for the imaging and measurement of retinal thickness.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Optical Coherence Tomography (OCT) under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Optical Coherence Tomography (OCT) and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Optical Coherence Tomography (OCT) under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Optical Coherence Tomography (OCT) Overview

3 Products under Development

• 3.1 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
• 3.2 Optical Coherence Tomography (OCT) - Pipeline Products by Territory
• 3.3 Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
• 3.4 Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
• 3.5 Optical Coherence Tomography (OCT) - Ongoing Clinical Trials

4 Optical Coherence Tomography (OCT) - Pipeline Products under Development by Companies

• 4.1 Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development
• 4.2 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development

5 Optical Coherence Tomography (OCT) Companies and Product Overview

• 5.1 Brown University Company Overview
  • 5.1.1 Brown University Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Canon USA Inc Company Overview
  • 5.2.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Columbia University Company Overview
  • 5.3.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 Compact Imaging Inc. Company Overview
  • 5.4.1 Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Costruzioni Strumenti Oftalmici Cso Srl Company Overview
  • 5.5.1 Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Digital Diagnostics Inc Company Overview
  • 5.6.1 Digital Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Duke University Company Overview
  • 5.7.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 George Washington University Company Overview
  • 5.8.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Heidelberg Engineering GmbH Company Overview
  • 5.9.1 Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Kubota Vision Inc Company Overview
  • 5.10.1 Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Leica Microsystems GmbH Company Overview
  • 5.11.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 LighTopTech Corp Company Overview
  • 5.12.1 LighTopTech Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Lumedica Inc Company Overview
  • 5.13.1 Lumedica Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Massachusetts General Hospital Company Overview
  • 5.14.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 MicroPort Scientific Corp Company Overview
  • 5.15.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Moorfields Eye Hospital NHS Foundation Trust Company Overview
  • 5.16.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Myriad Advanced Technologies LLC Company Overview
  • 5.17.1 Myriad Advanced Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Nippon Telegraph and Telephone Corp Company Overview
  • 5.18.1 Nippon Telegraph and Telephone Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 Notal Vision Inc Company Overview
  • 5.19.1 Notal Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 Opticent Inc Company Overview
  • 5.20.1 Opticent Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 OptoQuest Inc Company Overview
  • 5.21.1 OptoQuest Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 Optos Plc Company Overview
  • 5.22.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 OptoVibronex LLC Company Overview
  • 5.23.1 OptoVibronex LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 Optovue Inc Company Overview
  • 5.24.1 Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.25 Oregon Health & Science University Company Overview
  • 5.25.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview
• 5.26 Physical Sciences Inc Company Overview
  • 5.26.1 Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.27 Rowiak GmbH Company Overview
  • 5.27.1 Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.28 Singapore Eye Research Institute Company Overview
  • 5.28.1 Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview
• 5.29 Sinoora Inc. Company Overview
  • 5.29.1 Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.30 The University of Texas at Austin Division of Housing and Food Service Company Overview
  • 5.30.1 The University of Texas at Austin Division of Housing and Food Service Pipeline Products & Ongoing Clinical Trials Overview
• 5.31 Theia Imaging LLC Company Overview
  • 5.31.1 Theia Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.32 TowardPi Medical Technology Ltd Company Overview
  • 5.32.1 TowardPi Medical Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.33 Tupai (Beijing) Medical Technology Co Ltd Company Overview
  • 5.33.1 Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.34 University of California Berkeley Company Overview
  • 5.34.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
• 5.35 University of Illinois at Chicago Company Overview
  • 5.35.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
• 5.36 University of Liverpool Company Overview
  • 5.36.1 University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview
• 5.37 University of Louisville Company Overview
  • 5.37.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
• 5.38 University of Pittsburgh Company Overview
  • 5.38.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
• 5.39 University of Rochester Company Overview
  • 5.39.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
• 5.40 Vanderbilt University Company Overview
  • 5.40.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview

6 Optical Coherence Tomography (OCT)- Recent Developments

• 6.1 Apr 23, 2024: Topcon Receives Additional FDA 510(k) Clearance for 3D Optical Coherence Tomography (Maestro2)
• 6.2 Nov 15, 2023: Topcon Medical Systems Receives 510(K) Clearance For Maestro2
• 6.3 Nov 05, 2023: Heidelberg Engineering Receives Additional 510(K) Clearance for Spectralis HRA+OCT

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

• Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
• Optical Coherence Tomography (OCT) - Pipeline Products by Territory
• Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
• Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
• Optical Coherence Tomography (OCT) - Ongoing Clinical Trials
• Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development
• Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
• Glossary

List of Figures

• Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
• Optical Coherence Tomography (OCT) - Pipeline Products by Territory
• Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
• Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
• Optical Coherence Tomography (OCT) - Ongoing Clinical Trials